Skip to main content
. 2022 Apr 13;10(1):267–283. doi: 10.1016/j.gendis.2022.04.001

Figure 1.

Fig. 1

Kaplan–Meier plots in (A) PDAC, (B) CRC and (C) BC patient cohorts respectively, denoting that patient survival negatively correlated with PRMT5 expression in these groups of patients. Overall, PRMT5-high group had significant less overall survival (OS) than PRMT5-low group in all three cancer types. Time indicates the months after chemotherapy. Low vs. high: P = 0.00057 (PDAC); P = 0.041 (CRC); P = 0.0066. P-value less than 0.05 is considered to be statistically significant. The Kaplan–Meier plot analysis is fully described in the Method section.